Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00618410 · ClinicalTrials.gov registry record · NA
Intranasal CO2 for Allergic Rhinitis
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00618410 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 13 participants.
The verdict
NCT00618410, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the way in which CO2 (carbon dioxide) affects the symptoms of allergic rhinitis or hayfever. Our intent is to determine if CO2 has an effect on nasal challenge with antigen as a predictor of whether it will have a beneficial effect on the treatment of seasonal allergic rhinitis.
Interventions
- OTHER Placebo
- DEVICE Carbon dioxide, USP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00618410
The ClinicalTrials.gov registry entry for NCT00618410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00618410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00618410 about?
NCT00618410 is a clinical study titled "Intranasal CO2 for Allergic Rhinitis". The purpose of this study is to better understand the way in which CO2 (carbon dioxide) affects the symptoms of allergic rhinitis or hayfever. Our intent is to determine if CO2 has an effect on nasal challenge with antigen as a predictor of whether it will have a beneficial effect on the treatment ...
What is the current status of trial NCT00618410?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00618410?
The interventions under investigation include: Placebo (OTHER), Carbon dioxide, USP (DEVICE).
Who is sponsoring clinical trial NCT00618410?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.